Growth Hormone
Research overviews of growth-hormone-axis peptides and secretagogues — GHRH analogues and GHRP-class compounds such as ipamorelin, CJC-1295, sermorelin, tesamorelin, hexarelin, and MK-677 — summarizing what preclinical studies report.
MK-677 (Ibutamoren): A Research Overview of This Non-Peptide GH Secretagogue
MK-677 (ibutamoren) is a non-peptide ghrelin receptor agonist investigated in preclinical models for its ability to stimulate growth hormone and IGF-1 secretion. This overview summarizes the current state of laboratory research.
HGH 191aa Explained: What Researchers Need to Know About Recombinant Growth Hormone
HGH 191aa is a recombinant form of human growth hormone comprising the same 191-amino-acid sequence as the endogenous protein. This guide explores its molecular identity, preclinical research findings, and how it fits into the broader landscape of growth hormone biology.
Ipamorelin: A Review of Growth-Hormone-Axis Research
Ipamorelin is a selective growth-hormone secretagogue studied preclinically for its highly targeted action on the GH axis. This overview summarizes current research findings across receptor pharmacology, metabolic effects, and laboratory applications.
CJC-1295 Research: What Preclinical Studies Reveal About This GHRH Analogue
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH) that has attracted substantial preclinical interest for its extended half-life and ability to stimulate GH release in animal models. This overview summarizes what laboratory research currently shows.
GHRP-2 vs. GHRP-6: How the Preclinical Research Compares
GHRP-2 and GHRP-6 are both synthetic growth hormone secretagogues with overlapping yet distinct receptor profiles. This article breaks down what the preclinical literature reveals about each peptide.
Hexarelin: Mechanisms, Receptor Binding, and Preclinical Research Findings
Hexarelin is a synthetic hexapeptide studied for its potent growth hormone secretagogue activity and investigated in preclinical models for cardiovascular and metabolic applications. This overview covers its receptor pharmacology, in vitro and in vivo findings, and current research landscape.
GH vs. GHRH vs. GHRP: Untangling the Growth Hormone Axis
Growth hormone signaling involves three distinct tiers — GH itself, the releasing hormone GHRH, and the ghrelin-mimetic secretagogues called GHRPs. This article untangles how each tier works and why researchers study each class separately.
Tesamorelin: A Review of the Research Literature
Tesamorelin is a synthetic GHRH analog that has attracted significant scientific interest. This review examines what preclinical and clinical research has uncovered about its mechanisms and studied effects.
Sermorelin Research Overview: What Studies Reveal About This GHRH Analog
Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) that has been widely used in research to probe the GH/IGF-1 axis. This overview summarizes the key preclinical findings and the open questions researchers continue to investigate.